Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Roxadustat Reduces the Incidence of Acute Kidney Injury After Coronary Artery Bypass Grafting: a Multicenter, Randomized, Double-blind, Placebo-controlled Study

NCT05010460 is registered in ClinicalTrials.gov with Peking Union Medical College Hospital as lead sponsor.

NCT NCT05010460
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05010460 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Roxadustat Reduces the Incidence of Acute Kidney Injury After Coronary Artery Bypass Grafting: a Multicenter, Randomized, Double-blind, Placebo-controlled Study
Lead sponsor
Peking Union Medical College Hospital
Phase
Phase 2
Overall status
Terminated
Start date
September 30, 2021
Completion date
May 20, 2025
Enrollment
98 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery bypass